Share Price and Basic Stock Data
Last Updated: November 2, 2025, 1:21 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Cadsys (India) Ltd operates in the IT Enabled Services sector and has shown notable fluctuations in its revenue over the past few years. The company’s sales reported for the fiscal year ending March 2023 stood at ₹175 Cr, a significant increase from ₹67 Cr in March 2022. This upward trend continued with reported sales of ₹215 Cr for March 2024, although a decline to ₹100 Cr is expected for March 2025. Quarterly sales also exhibited volatility; for instance, sales rose from ₹51 Cr in March 2022 to ₹101 Cr in March 2023 and further to ₹108 Cr in September 2023. However, the company faces challenges, as evidenced by the declining sales forecast for March 2025 and the decrease in quarterly sales to ₹60 Cr in September 2024. Overall, while Cadsys has demonstrated strong growth in recent periods, the anticipated decline indicates potential headwinds ahead.
Profitability and Efficiency Metrics
The profitability metrics of Cadsys (India) Ltd reflect a complex landscape. For the fiscal year ending March 2023, the company reported an operating profit margin (OPM) of 7%, which is a significant recovery from the negative margins recorded in previous years. However, the OPM is expected to decline sharply to -29% in March 2025, indicative of potential operational inefficiencies. The net profit for March 2023 stood at ₹7 Cr, which is a turnaround from losses in preceding years, but it is projected to plummet to -₹69 Cr in March 2025. The interest coverage ratio (ICR) reported at 3.63x for March 2024 is relatively healthy, suggesting that the company can comfortably meet its interest obligations. Nevertheless, the high cash conversion cycle of 329 days raises concerns regarding liquidity and operational efficiency, which could hinder profitability if not addressed.
Balance Sheet Strength and Financial Ratios
Cadsys (India) Ltd’s balance sheet showcases both resilience and vulnerabilities. As of March 2024, total borrowings stood at ₹112 Cr, a sharp increase from ₹81 Cr in March 2023. In contrast, reserves decreased to ₹19 Cr from ₹50 Cr during the same period, raising concerns over the company’s capital structure. The total liabilities reported at ₹205 Cr, against total assets of ₹246 Cr, indicate a reasonable asset coverage for liabilities. The return on equity (ROE) at 50.5% suggests effective utilization of shareholder funds, although the return on capital employed (ROCE) at 16.9% is modest compared to industry standards. The price-to-book value ratio (P/BV) of 2.96x indicates that the stock is trading at a premium, which may reflect investor confidence despite the underlying risks in profitability. Overall, while the balance sheet reflects some strength, the rising debt levels and declining reserves warrant close scrutiny.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cadsys (India) Ltd reveals a mixed sentiment among stakeholders. As of March 2025, promoters hold a significant 47.78% of the company, demonstrating strong insider confidence. However, the public’s stake is slightly higher at 52.22%, indicating a reliance on retail investors. Notably, foreign institutional investors (FIIs) have not invested in the company, while domestic institutional investors (DIIs) hold no stake, reflecting a lack of institutional confidence. The number of shareholders has fluctuated significantly, with a notable increase to 964 in March 2025 from 363 in September 2023, suggesting growing interest among retail investors. Despite the high promoter holding, the absence of institutional backing may affect long-term stability and growth prospects, as institutional investors often provide a stabilizing influence in volatile markets.
Outlook, Risks, and Final Insight
The outlook for Cadsys (India) Ltd is tempered by both opportunities and risks. On the positive side, the company has shown impressive revenue growth in recent years and has maintained a high ROE, indicating effective management of equity. However, the projected decline in sales and profitability, particularly the anticipated net loss of ₹69 Cr for March 2025, raises significant concerns about operational sustainability. The high cash conversion cycle and increasing debt levels further exacerbate these risks. Investors should also be wary of the lack of institutional support, which may lead to increased volatility. In conclusion, while Cadsys has demonstrated resilience and growth potential, the looming financial challenges necessitate cautious monitoring. The company’s future hinges on its ability to navigate these risks and improve operational efficiency, as well as attract institutional interest to bolster its financial standing.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cadsys (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| N2N Technologies Ltd | 9.68 Cr. | 30.0 | 30.5/14.2 | 6.82 | 21.4 | 0.00 % | 19.6 % | 22.4 % | 10.0 |
| eMudhra Ltd | 5,296 Cr. | 640 | 1,024/625 | 57.8 | 90.0 | 0.20 % | 15.3 % | 12.1 % | 5.00 |
| BNR Udyog Ltd | 14.7 Cr. | 49.0 | 90.0/44.5 | 32.3 | 0.00 % | 10.0 % | 5.52 % | 10.0 | |
| BLS E-Services Ltd | 1,829 Cr. | 200 | 249/131 | 33.1 | 53.1 | 0.50 % | 15.8 % | 11.0 % | 10.0 |
| BGIL Films & Technologies Ltd | 25.3 Cr. | 22.4 | 24.7/4.93 | 16.9 | 0.00 % | 0.34 % | 0.88 % | 10.0 | |
| Industry Average | 8,172.87 Cr | 685.99 | 34.62 | 185.05 | 0.41% | 20.05% | 20.85% | 7.41 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 23 | 18 | 12 | 19 | 16 | 51 | 73 | 101 | 108 | 107 | 60 | 41 |
| Expenses | 22 | 19 | 20 | 15 | 20 | 18 | 53 | 79 | 84 | 94 | 96 | 67 | 64 |
| Operating Profit | 8 | 5 | -2 | -2 | -1 | -2 | -2 | -5 | 17 | 14 | 12 | -7 | -24 |
| OPM % | 26% | 20% | -10% | -19% | -4% | -12% | -3% | -7% | 16% | 13% | 11% | -11% | -58% |
| Other Income | 1 | 0 | 2 | 0 | 3 | 0 | 4 | 2 | 3 | 1 | 2 | 0 | -27 |
| Interest | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 2 | 4 | 4 | 4 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 2 | 2 |
| Profit before tax | 7 | 2 | -2 | -4 | -0 | -4 | -1 | -7 | 15 | 8 | 7 | -12 | -56 |
| Tax % | 7% | -10% | 0% | 11% | 24% | 7% | 46% | 7% | -1% | 4% | 3% | 1% | 1% |
| Net Profit | 6 | 2 | -2 | -5 | -1 | -4 | -1 | -8 | 15 | 7 | 7 | -12 | -56 |
| EPS in Rs | 8.64 | 3.24 | -2.84 | -6.41 | -0.75 | -5.01 | -1.05 | -5.69 | 11.94 | 6.36 | 4.39 | -7.17 | -29.88 |
Last Updated: May 31, 2025, 9:35 am
Below is a detailed analysis of the quarterly data for Cadsys (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Sep 2024) to 41.00 Cr., marking a decrease of 19.00 Cr..
- For Expenses, as of Mar 2025, the value is 64.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 67.00 Cr. (Sep 2024) to 64.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Mar 2025, the value is -24.00 Cr.. The value appears to be declining and may need further review. It has decreased from -7.00 Cr. (Sep 2024) to -24.00 Cr., marking a decrease of 17.00 Cr..
- For OPM %, as of Mar 2025, the value is -58.00%. The value appears to be declining and may need further review. It has decreased from -11.00% (Sep 2024) to -58.00%, marking a decrease of 47.00%.
- For Other Income, as of Mar 2025, the value is -27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Sep 2024) to -27.00 Cr., marking a decrease of 27.00 Cr..
- For Interest, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -56.00 Cr.. The value appears to be declining and may need further review. It has decreased from -12.00 Cr. (Sep 2024) to -56.00 Cr., marking a decrease of 44.00 Cr..
- For Tax %, as of Mar 2025, the value is 1.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00%.
- For Net Profit, as of Mar 2025, the value is -56.00 Cr.. The value appears to be declining and may need further review. It has decreased from -12.00 Cr. (Sep 2024) to -56.00 Cr., marking a decrease of 44.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -29.88. The value appears to be declining and may need further review. It has decreased from -7.17 (Sep 2024) to -29.88, marking a decrease of 22.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20 | 24 | 30 | 42 | 45 | 52 | 42 | 31 | 67 | 175 | 215 | 100 |
| Expenses | 15 | 16 | 22 | 26 | 31 | 34 | 38 | 34 | 70 | 162 | 189 | 129 |
| Operating Profit | 5 | 8 | 8 | 16 | 14 | 18 | 3 | -2 | -3 | 13 | 26 | -29 |
| OPM % | 24% | 34% | 27% | 38% | 31% | 34% | 8% | -7% | -4% | 7% | 12% | -29% |
| Other Income | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | 3 | -27 |
| Interest | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 8 | 7 |
| Depreciation | 1 | 1 | 1 | 3 | 4 | 3 | 4 | 4 | 4 | 5 | 6 | 5 |
| Profit before tax | 4 | 7 | 8 | 12 | 9 | 15 | 0 | -5 | -4 | 8 | 14 | -68 |
| Tax % | 27% | 36% | 32% | 10% | 16% | 18% | -367% | 12% | 15% | 5% | 4% | 1% |
| Net Profit | 3 | 5 | 6 | 11 | 7 | 12 | 0 | -5 | -5 | 7 | 14 | -69 |
| EPS in Rs | 27.49 | 43.31 | 51.09 | 20.27 | 9.86 | 16.55 | 0.40 | -7.16 | -6.06 | 6.25 | 10.73 | -37.04 |
| Dividend Payout % | 36% | 23% | 4% | 5% | 10% | 8% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 66.67% | 20.00% | 83.33% | -36.36% | 71.43% | -100.00% | 0.00% | 240.00% | 100.00% | -592.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | -46.67% | 63.33% | -119.70% | 107.79% | -171.43% | 100.00% | 240.00% | -140.00% | -692.86% |
Cadsys (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 19% |
| 3 Years: | 15% |
| TTM: | -53% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -376% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 19% |
| 1 Year: | -49% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -10% |
| 3 Years: | -6% |
| Last Year: | -50% |
Last Updated: September 5, 2025, 1:25 am
Balance Sheet
Last Updated: October 10, 2025, 1:48 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 10 |
| Reserves | 8 | 12 | 17 | 24 | 42 | 55 | 49 | 44 | 43 | 43 | 50 | 19 |
| Borrowings | 2 | 5 | 6 | 17 | 7 | 6 | 13 | 18 | 36 | 81 | 84 | 112 |
| Other Liabilities | 6 | 5 | 4 | 9 | 4 | 7 | 4 | 4 | 31 | 62 | 105 | 63 |
| Total Liabilities | 17 | 23 | 29 | 55 | 60 | 75 | 73 | 73 | 117 | 193 | 246 | 205 |
| Fixed Assets | 4 | 4 | 5 | 16 | 30 | 32 | 33 | 30 | 54 | 79 | 74 | 67 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 7 | 0 | 2 | 10 |
| Investments | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Other Assets | 13 | 19 | 23 | 39 | 29 | 42 | 40 | 35 | 55 | 114 | 170 | 127 |
| Total Assets | 17 | 23 | 29 | 55 | 60 | 75 | 73 | 73 | 117 | 193 | 246 | 205 |
Below is a detailed analysis of the balance sheet data for Cadsys (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2024) to 19.00 Cr., marking a decrease of 31.00 Cr..
- For Borrowings, as of Mar 2025, the value is 112.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 84.00 Cr. (Mar 2024) to 112.00 Cr., marking an increase of 28.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 63.00 Cr.. The value appears to be improving (decreasing). It has decreased from 105.00 Cr. (Mar 2024) to 63.00 Cr., marking a decrease of 42.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 205.00 Cr.. The value appears to be improving (decreasing). It has decreased from 246.00 Cr. (Mar 2024) to 205.00 Cr., marking a decrease of 41.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2024) to 67.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 8.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2024) to 127.00 Cr., marking a decrease of 43.00 Cr..
- For Total Assets, as of Mar 2025, the value is 205.00 Cr.. The value appears to be declining and may need further review. It has decreased from 246.00 Cr. (Mar 2024) to 205.00 Cr., marking a decrease of 41.00 Cr..
However, the Borrowings (112.00 Cr.) are higher than the Reserves (19.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.00 | 3.00 | 2.00 | -1.00 | 7.00 | 12.00 | -10.00 | -20.00 | -39.00 | -68.00 | -58.00 | -141.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 36 | 42 | 80 | 68 | 79 | 187 | 178 | 145 | 128 | 166 | 329 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 6 | 36 | 42 | 80 | 68 | 79 | 187 | 178 | 145 | 128 | 166 | 329 |
| Working Capital Days | -48 | -58 | -48 | 16 | 89 | 72 | 200 | 201 | 78 | 105 | 117 | 204 |
| ROCE % | 40% | 54% | 42% | 40% | 21% | 25% | 0% | -9% | -6% | 9% | 12% | -17% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 10.73 | 6.25 | -6.07 | -7.15 | 0.40 |
| Diluted EPS (Rs.) | 10.73 | 6.25 | -6.07 | -7.15 | 0.40 |
| Cash EPS (Rs.) | 26.46 | 16.19 | -2.31 | -2.46 | 5.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 165.21 | 98.60 | 87.84 | 67.96 | 75.01 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 165.21 | 98.60 | 87.84 | 67.96 | 75.01 |
| Revenue From Operations / Share (Rs.) | 286.72 | 232.13 | 89.37 | 41.97 | 55.51 |
| PBDIT / Share (Rs.) | 37.02 | 21.21 | -3.28 | -3.65 | 4.97 |
| PBIT / Share (Rs.) | 29.04 | 14.98 | -7.63 | -8.36 | -0.17 |
| PBT / Share (Rs.) | 19.22 | 10.48 | -5.80 | -6.39 | 0.08 |
| Net Profit / Share (Rs.) | 18.49 | 9.96 | -6.66 | -7.17 | 0.38 |
| NP After MI And SOA / Share (Rs.) | 10.73 | 6.25 | -6.07 | -7.15 | 0.39 |
| PBDIT Margin (%) | 12.91 | 9.13 | -3.67 | -8.70 | 8.95 |
| PBIT Margin (%) | 10.12 | 6.45 | -8.54 | -19.92 | -0.32 |
| PBT Margin (%) | 6.70 | 4.51 | -6.48 | -15.22 | 0.15 |
| Net Profit Margin (%) | 6.44 | 4.29 | -7.45 | -17.07 | 0.68 |
| NP After MI And SOA Margin (%) | 3.74 | 2.69 | -6.78 | -17.04 | 0.71 |
| Return on Networth / Equity (%) | 14.08 | 9.28 | -9.07 | -10.48 | 0.53 |
| Return on Capital Employeed (%) | 13.99 | 7.82 | -6.07 | -9.09 | -0.20 |
| Return On Assets (%) | 3.27 | 2.42 | -3.89 | -7.39 | 0.40 |
| Long Term Debt / Equity (X) | 0.44 | 1.24 | 0.52 | 0.33 | 0.16 |
| Total Debt / Equity (X) | 1.46 | 1.48 | 0.66 | 0.34 | 0.21 |
| Asset Turnover Ratio (%) | 0.98 | 0.23 | 0.24 | 0.17 | 0.27 |
| Current Ratio (X) | 1.86 | 2.22 | 2.25 | 8.26 | 5.18 |
| Quick Ratio (X) | 1.86 | 2.22 | 2.25 | 8.26 | 5.18 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 313.05 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 22.53 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | -213.05 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 77.47 |
| Interest Coverage Ratio (X) | 3.63 | 4.71 | -1.58 | -2.56 | 3.81 |
| Interest Coverage Ratio (Post Tax) (X) | 2.77 | 3.21 | -4.09 | -6.41 | 0.08 |
| Enterprise Value (Cr.) | 311.32 | 121.21 | 65.67 | 23.18 | 20.63 |
| EV / Net Operating Revenue (X) | 1.45 | 0.69 | 0.97 | 0.73 | 0.49 |
| EV / EBITDA (X) | 11.21 | 7.62 | -26.67 | -8.45 | 5.53 |
| MarketCap / Net Operating Revenue (X) | 0.78 | 0.18 | 0.45 | 0.45 | 0.31 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | -213.05 |
| Price / BV (X) | 2.96 | 0.65 | 0.60 | 0.27 | 0.23 |
| Price / Net Operating Revenue (X) | 0.78 | 0.18 | 0.45 | 0.45 | 0.31 |
| EarningsYield | 0.04 | 0.14 | -0.14 | -0.37 | 0.02 |
After reviewing the key financial ratios for Cadsys (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 10.73. This value is within the healthy range. It has increased from 6.25 (Mar 23) to 10.73, marking an increase of 4.48.
- For Diluted EPS (Rs.), as of Mar 24, the value is 10.73. This value is within the healthy range. It has increased from 6.25 (Mar 23) to 10.73, marking an increase of 4.48.
- For Cash EPS (Rs.), as of Mar 24, the value is 26.46. This value is within the healthy range. It has increased from 16.19 (Mar 23) to 26.46, marking an increase of 10.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 165.21. It has increased from 98.60 (Mar 23) to 165.21, marking an increase of 66.61.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 165.21. It has increased from 98.60 (Mar 23) to 165.21, marking an increase of 66.61.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 286.72. It has increased from 232.13 (Mar 23) to 286.72, marking an increase of 54.59.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 37.02. This value is within the healthy range. It has increased from 21.21 (Mar 23) to 37.02, marking an increase of 15.81.
- For PBIT / Share (Rs.), as of Mar 24, the value is 29.04. This value is within the healthy range. It has increased from 14.98 (Mar 23) to 29.04, marking an increase of 14.06.
- For PBT / Share (Rs.), as of Mar 24, the value is 19.22. This value is within the healthy range. It has increased from 10.48 (Mar 23) to 19.22, marking an increase of 8.74.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 18.49. This value is within the healthy range. It has increased from 9.96 (Mar 23) to 18.49, marking an increase of 8.53.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.73. This value is within the healthy range. It has increased from 6.25 (Mar 23) to 10.73, marking an increase of 4.48.
- For PBDIT Margin (%), as of Mar 24, the value is 12.91. This value is within the healthy range. It has increased from 9.13 (Mar 23) to 12.91, marking an increase of 3.78.
- For PBIT Margin (%), as of Mar 24, the value is 10.12. This value is within the healthy range. It has increased from 6.45 (Mar 23) to 10.12, marking an increase of 3.67.
- For PBT Margin (%), as of Mar 24, the value is 6.70. This value is below the healthy minimum of 10. It has increased from 4.51 (Mar 23) to 6.70, marking an increase of 2.19.
- For Net Profit Margin (%), as of Mar 24, the value is 6.44. This value is within the healthy range. It has increased from 4.29 (Mar 23) to 6.44, marking an increase of 2.15.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.74. This value is below the healthy minimum of 8. It has increased from 2.69 (Mar 23) to 3.74, marking an increase of 1.05.
- For Return on Networth / Equity (%), as of Mar 24, the value is 14.08. This value is below the healthy minimum of 15. It has increased from 9.28 (Mar 23) to 14.08, marking an increase of 4.80.
- For Return on Capital Employeed (%), as of Mar 24, the value is 13.99. This value is within the healthy range. It has increased from 7.82 (Mar 23) to 13.99, marking an increase of 6.17.
- For Return On Assets (%), as of Mar 24, the value is 3.27. This value is below the healthy minimum of 5. It has increased from 2.42 (Mar 23) to 3.27, marking an increase of 0.85.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.44. This value is within the healthy range. It has decreased from 1.24 (Mar 23) to 0.44, marking a decrease of 0.80.
- For Total Debt / Equity (X), as of Mar 24, the value is 1.46. This value exceeds the healthy maximum of 1. It has decreased from 1.48 (Mar 23) to 1.46, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.98. It has increased from 0.23 (Mar 23) to 0.98, marking an increase of 0.75.
- For Current Ratio (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has decreased from 2.22 (Mar 23) to 1.86, marking a decrease of 0.36.
- For Quick Ratio (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has decreased from 2.22 (Mar 23) to 1.86, marking a decrease of 0.36.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 3.63. This value is within the healthy range. It has decreased from 4.71 (Mar 23) to 3.63, marking a decrease of 1.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.77. This value is below the healthy minimum of 3. It has decreased from 3.21 (Mar 23) to 2.77, marking a decrease of 0.44.
- For Enterprise Value (Cr.), as of Mar 24, the value is 311.32. It has increased from 121.21 (Mar 23) to 311.32, marking an increase of 190.11.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.45. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 1.45, marking an increase of 0.76.
- For EV / EBITDA (X), as of Mar 24, the value is 11.21. This value is within the healthy range. It has increased from 7.62 (Mar 23) to 11.21, marking an increase of 3.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 23) to 0.78, marking an increase of 0.60.
- For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Price / BV (X), as of Mar 24, the value is 2.96. This value is within the healthy range. It has increased from 0.65 (Mar 23) to 2.96, marking an increase of 2.31.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 23) to 0.78, marking an increase of 0.60.
- For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.04, marking a decrease of 0.10.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cadsys (India) Ltd:
- Net Profit Margin: 6.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 13.99% (Industry Average ROCE: 20.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.08% (Industry Average ROE: 20.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.77
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.86
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 34.62)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.44%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Enabled Services | Office # 803, 8th Floor, DSL Abacus IT Park, Hyderabad Telangana 500039 | info@cadsystech.com http://www.cadsystech.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nallani Chakravarthi Venkata Rangacharya | Managing Director |
| Mrs. Nallani Chakravarthi Padmaja | Whole Time Director |
| Mr. Sai Sridhar Sangineni | Independent Director |
| Mr. Appalacharyulu Chilakamarri | Independent Director |
| Mrs. Chilakamarri Madhavi | Non Executive Director |
| Mr. Sripadarajan Nagarajan | Executive Director |
FAQ
What is the intrinsic value of Cadsys (India) Ltd?
Cadsys (India) Ltd's intrinsic value (as of 03 November 2025) is 180.49 which is 152.43% higher the current market price of 71.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 71.5 Cr. market cap, FY2025-2026 high/low of 140/55.0, reserves of ₹19 Cr, and liabilities of 205 Cr.
What is the Market Cap of Cadsys (India) Ltd?
The Market Cap of Cadsys (India) Ltd is 71.5 Cr..
What is the current Stock Price of Cadsys (India) Ltd as on 03 November 2025?
The current stock price of Cadsys (India) Ltd as on 03 November 2025 is 71.5.
What is the High / Low of Cadsys (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cadsys (India) Ltd stocks is 140/55.0.
What is the Stock P/E of Cadsys (India) Ltd?
The Stock P/E of Cadsys (India) Ltd is .
What is the Book Value of Cadsys (India) Ltd?
The Book Value of Cadsys (India) Ltd is 29.2.
What is the Dividend Yield of Cadsys (India) Ltd?
The Dividend Yield of Cadsys (India) Ltd is 0.00 %.
What is the ROCE of Cadsys (India) Ltd?
The ROCE of Cadsys (India) Ltd is 16.9 %.
What is the ROE of Cadsys (India) Ltd?
The ROE of Cadsys (India) Ltd is 50.5 %.
What is the Face Value of Cadsys (India) Ltd?
The Face Value of Cadsys (India) Ltd is 10.0.